Search

everythinglearnresearchcommunity

for

Search:↓

Low hemoglobin levels are significantly correlated with hair loss in women with Telogen Effluvium.

People with telogen effluvium often have much lower vitamin D levels than healthy individuals.

COVID-19 infection can cause temporary hair loss due to stress, treatment drugs, psychological impact, and pandemic-related stress.

Thyroid dysfunction, vitamin D and B12 deficiencies, and iron deficiency may be linked to hair loss condition Telogen Effluvium.

Low iron and vitamin D3 levels might be major causes of hair loss in Iraqi women.

Telogen Effluvium causes more hair loss because hair moves to the resting phase too soon.

Telogen effluvium is a condition that causes temporary hair loss due to stress or shock to the body.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.

Higher Vitamin-D levels may help treat certain types of hair loss.

Low iron levels in the blood could be a sign of Telogen Effluvium, a type of hair loss, but it's not always accurate in distinguishing it from other hair loss types.

Wearing a hijab is linked to a higher risk of hair loss.

Red LED light therapy helps reduce hair loss and improves hair regrowth in long COVID patients.

Using Favipiravir, a COVID-19 treatment drug, likely doesn't cause hair loss.

Dengue fever can cause hair loss that may lead to serious psychological issues like Body Dysmorphic Disorder in young women.

Trichoscopy effectively differentiates Androgenetic Alopecia from Telogen Effluvium.

The treatment improved hair growth and thickness in patients with hair loss, even 10 months after therapy without additional products.

The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.

Recognizing the different stages of alopecia areata is crucial for accurate diagnosis and treatment.

Most women aged 20-40 in the study lost hair diffusely and in volume over 6 weeks to 6 months, mainly due to telogen effluvium, often without a clear cause.

Many dermatologists in Saudi Arabia recommend vitamins and minerals for hair loss, often based on personal experience rather than strong evidence.

Higher iron levels in the blood are not linked to increased hair loss in women.

People with Inflammatory Bowel Disease often lose hair due to stress, medication side effects, or lack of nutrients, and treatment depends on the specific cause.

Alopecia Areata Incognita causes widespread hair thinning, and treatment with systemic corticosteroids and psychiatric support can lead to remission.

The author clarified that Alopecia Areata Incognita (AAI) and diffuse Alopecia Areata (AA) are different conditions and the case discussed was actually AA, not AAI.

Two teenage brothers had a rare, treatment-resistant form of female-pattern hair loss with unusual scalp changes.

A new hair loss classification for women improves treatment, but careful patient selection is crucial for successful hair transplantation.

A woman's hair loss was treated successfully with iron supplements for her iron deficiency.